• OPEN AN ACCOUNT
Indian Indices
Sensex
81,537.70 -769.67
( -0.94%)
Global Indices
Nasdaq
49,128.98 -276.04
(-0.56%)
Dow Jones
6,938.97 4.62
(0.07%)
Hang Seng
53,831.56 142.67
(0.27%)
Nikkei 225
10,138.52 -11.53
(-0.11%)
Forex
USD-INR
91.58 0.09
(0.10%)
EUR-INR
107.27 0.14
(0.13%)
GBP-INR
123.20 0.33
(0.27%)
JPY-INR
0.58 0.00
(-0.17%)

EQUITY - MARKET SCREENER

Goodluck India Ltd
Industry :  Steel - Medium / Small
BSE Code
ISIN Demat
Book Value()
530655
INE127I01024
391.6050094
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GOODLUCK
20.76
3397.31
EPS(TTM)
Face Value()
Div & Yield %
49.23
2
0.39
 

Aurobindo Pharma arm gets Form-483 with five observations
Dec 18,2025
The inspection was conducted from 8 December to 17 December 2025. At the end of the current inspection, a ‘Form 483’ was issued with 5 observations which are procedural in nature, and the company said that it will respond to the US FDA within the stipulated timelines.

Aurobindo Pharma is principally engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals, and related services.

The company’s consolidated net profit increased 3.8% to Rs 848.45 crore on 7.7% increase in net sales to Rs 8,236.96 crore in Q2 FY26 over Q2 FY25.

The scrip rose 0.36% to Rs 1,197.40 on the BSE.